共 357 条
[1]
Theoharides TC(2015)Mast cells, mastocytosis, and related disorders N Engl J Med 373 163-172
[2]
Valent P(2022)Global classification of mast cell activation disorders: an ICD-10-CM-adjusted proposal of the ECNM-AIM consortium J Allergy Clin Immunol Pract 10 1941-1950
[3]
Akin C(2021)Mast cell activation syndrome: is anaphylaxis part of the phenotype? A systematic review Curr Opin Allergy Clin Immunol 21 426-434
[4]
Valent P(2023)Increased excretion of mast cell mediator metabolites during mast cell activation syndrome J Allergy Clin Immunol Pract 11 2542-2546
[5]
Hartmann K(2019)Why the 20% + 2 tryptase formula is a diagnostic gold standard for severe systemic mast cell activation and mast cell activation syndrome Int Arch Allergy Immunol 180 44-51
[6]
Bonadonna P(2022)Personalized management strategies in mast cell disorders: ECNM-AIM user’s guide for daily clinical practice J Allergy Clin Immunol Pract 10 1999-2012.e6
[7]
Gulen T(2018)EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy Allergy 73 744-764
[8]
Brockow K(2019)AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management J Allergy Clin Immunol 144 883-896
[9]
Alvarez-Twose I(1983)A double-blind cross-over study of the effect of ketotifen in urticaria pigmentosa Dermatologica 166 44-47
[10]
Sabato V(1993)Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis J Allergy Clin Immunol 92 520-526